Navigation Links
Chantel Christie Named Youth Ambassador for HIV/AIDS Awareness by Metro TeenAIDS Organization
Date:10/26/2007

WASHINGTON, Oct. 26 /PRNewswire/ -- Chantel Christie, daughter of NBA power couple, Doug and Jackie Christie, is being named the Metro TeenAIDS Youth Ambassador for HIV/AIDS Awareness on November 17, 2007 by Metro TeenAIDS, and various city officials will be in attendance. As the new spokesperson for Metro TeenAIDS Organization, Christie will reach out to the youth on HIV/AIDS Awareness and encourage youth nationally to get HIV tested. This inauguration starts at 2:00 P.M. (EST) at the Hill Crest Recreation Center located at 1300 Denver Street, South East Washington, D.C. 20020.

Chantel Christie has a passion to lead youth across the world as a positive role model. Earlier this fall, she was chosen as the Kids Outreach Spokesperson for the YMCA of Metropolitan Washington for 2008. Chantel also has a new reality show titled "Coming Up Christie" where she goes through the vigorous works of releasing her first single called "Best Friends" within the music industry.

"Growing up as a Christie has taught me the values of leaving a positive impact on the community. I am excited about my new ventures and working with kids across the globe," says Chantel. During the inauguration ceremony, Chantel will facilitate a Question and Answer Session on the topic of HIV/AIDS.

During the event, guests attending will enjoy personal spoken word from Chantel as well as giveaways from The Doug and Jackie Christie Infinite Love Foundation HIV/AIDS awareness.

About Metro TeenAIDS:

Metro TeenAIDS is a community health organization dedicated to supporting young people in the fight against HIV/AIDS. Through education, support, and advocacy, MTA prevents the spread of HIV, promotes responsible decision making, and improves the quality of life for young people infected with, or affected by, HIV/AIDS.

Unlike any other organization in the Washington, DC area, Metro TeenAIDS focuses all of its efforts on the special prevention, education, and treatment nee
'/>"/>

SOURCE Metro TeenAIDS
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. UP government decides to suspend doctor named in sting operation
2. Yale Researchers Named Ellison Foundation Senior Scholars in Aging
3. Brian Lara Opens Cancer Center Named After Him
4. Bat Virus Renamed After Protests from Malaysia State
5. Inadequate Drug Treatment For Youth
6. Abuse of prescription drugs among youths on the rise
7. Genetic mutation to the fountain of youth discovered
8. Cosmetic plastic surgery for a youthful healthy look
9. Canadian Youth at risk of heart disease
10. Youth Becoming Sexually Active At A Younger Age
11. Drug Use On The Decline Among US Youth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...r University Medical Center at Dallas and the Bayl...introduce insulin genes into the pancreas//. Ins... sugar) to enter the cells of the body to be used ...ltrasound-targeted micro bubble destruction (UTMD)...
...uota issue between government and striking medicos...ing with their demand of setting up an experts com...riking medicos are also expected to meet Union Hea...r in the day. The resident doctors association of...
...ug Administration authority is under pressure as i...rug as an over-the counter drug//. Andrew von Esc...rged to take an independent, non-biased decision o...d to sell its morning after pill or Plan B without...
...ior doctors of Sir Sunderlal hospital in the Banar...unger strike// for the second consecutive day toda...a for the backward castes in the higher education ...nger strike, the agitating doctors formed human ch...
Other Medicine News:Health News:Bubble Technique on the cards For Treatment of Type I diabetes 2
(Date:10/6/2008)... Annual Scientific Conference -, ORLANDO, Fla., O...rmerly Microbia) today announced presentation of d... the role that cyclic guanosine,monophosphate (cGM...dies,demonstrate that cGMP inhibits intestinal pai...a and desensitizes colonic afferent nerves in a,si...
(Date:10/6/2008)...MICADE Therapy is More Likely to Induce Steroid-...tandard Immunomodulator, Azath...ta presented for the first time,from the Phase 3b ...munomodulators and Biologic Therapy (SONIC) may pr...tients with moderate to severe Crohn,s disease.,Ac...
(Date:10/6/2008)...eristics of Naltrexone SR Associated with ...PHOENIX, Oct. 6 /- Orexigen...eutical company focused on the treatment of,obesit...rs, today presented,data showing the investigation...), successfully achieved key objectives (lowered n...
(Date:10/5/2008)...nd Journal of Medicine reaffirm,well-established e...,HandiHaler(R), RIDGEFIELD, Conn., and NEW YORK, ...rstanding Potential Long-term Impacts on Function ...diHaler(R) (tiotropium bromide,inhalation powder),... 4,years as measured by FEV(1) (p<0.001) versus pl...
Breaking Medicine Technology:Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 3Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 4Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 6Argosy publishing launches The Visible Body 13442 1Argosy publishing launches The Visible Body 13442 2Argosy publishing launches The Visible Body 13442 3Sleep Medicine Associates Opens New Doors at Swedish Cherry Hill Campus 13437 1Sleep Medicine Associates Opens New Doors at Swedish Cherry Hill Campus 13437 2Diamonds Retirement Study Finds Companies Ill Prepared to Meet Baby Boomers Health and Wealth Needs 13434 1Diamonds Retirement Study Finds Companies Ill Prepared to Meet Baby Boomers Health and Wealth Needs 13434 2Diamonds Retirement Study Finds Companies Ill Prepared to Meet Baby Boomers Health and Wealth Needs 13434 3Diamonds Retirement Study Finds Companies Ill Prepared to Meet Baby Boomers Health and Wealth Needs 13434 4Diamonds Retirement Study Finds Companies Ill Prepared to Meet Baby Boomers Health and Wealth Needs 13434 5New potential drug target for the treatment of atherosclerosis 13430 1New potential drug target for the treatment of atherosclerosis 13430 2New potential drug target for the treatment of atherosclerosis 13430 3
... -- Genotypically Optimized Dosing Results in Impr... -- , MELBOURNE, Australia, and MENLO PARK, Califo...s (ASX: CXS, NASDAQ: CXSP) announced,today the pre...ydrochloride) phase 1/2a dose-escalation study, de...of Quinamed in heavily,pre-treated patients with a...
... Data From the Companies, Novel Heat Shock Protein...olerability, and Biological,Activity , CAMBRIDGE, ...EWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq...ounced updated interim,results from a Phase I clin... (Hsp90) inhibitor, IPI-504, in patients with rela...
Other Medicine Technology:ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO 2ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO 3ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO 4Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 2Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 3Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 4Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 5Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 6Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 7
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
Medicine Products: